Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L9AJ
|
|||
| Former ID |
DCL000982
|
|||
| Drug Name |
Seletracetam
|
|||
| Synonyms |
UCB 44212; UCB-44212; 2-[4-(2,2-difluoroethenyl)-2-oxo-pyrrolidin-1-yl]butanamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Epilepsy [ICD-11: 8A60-8A68] | Discontinued in Phase 3 | [1] | |
| Company |
UCB Pharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H14F2N2O2
|
|||
| Canonical SMILES |
CCC(C(=O)N)N1CC(CC1=O)C=C(F)F
|
|||
| InChI |
1S/C10H14F2N2O2/c1-2-7(10(13)16)14-5-6(3-8(11)12)4-9(14)15/h3,6-7H,2,4-5H2,1H3,(H2,13,16)/t6-,7+/m1/s1
|
|||
| InChIKey |
ANWPENAPCIFDSZ-RQJHMYQMSA-N
|
|||
| CAS Number |
CAS 357336-74-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Synaptic vesicle glycoprotein 2A (SV2A) | Target Info | Binder | [1] |
| KEGG Pathway | ECM-receptor interaction | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for epilepsy. Expert Opin Emerg Drugs. 2007 Sep;12(3):407-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.